Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Preferred Shares (2023 - 2025)

Lucid Diagnostics' Preferred Shares history spans 3 years, with the latest figure at $54.3 million for Q4 2025.

  • For Q4 2025, Preferred Shares changed 0.27% year-over-year to $54.3 million; the TTM value through Dec 2025 reached $54.3 million, changed 0.27%, while the annual FY2025 figure was $54.3 million, 0.27% changed from the prior year.
  • Preferred Shares reached $54.3 million in Q4 2025 per LUCD's latest filing, roughly flat from $54.3 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $55.9 million in Q2 2024 to a low of $13.6 million in Q1 2023.
  • Average Preferred Shares over 3 years is $40.6 million, with a median of $54.3 million recorded in 2025.
  • Peak YoY movement for Preferred Shares: skyrocketed 310.41% in 2024, then dropped 2.94% in 2025.
  • A 3-year view of Preferred Shares shows it stood at $18.6 million in 2023, then soared by 192.18% to $54.4 million in 2024, then dropped by 0.27% to $54.3 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Preferred Shares are $54.3 million (Q4 2025), $54.3 million (Q3 2025), and $54.4 million (Q2 2025).